Literature DB >> 25838666

Octreotide for conservative management of intractable high output post operative chylous fistula: a case report.

Sundararaman Prabhu1, Shaji Thomas1.   

Abstract

A case of high output post neck dissection chylous fistula is presented, which was successfully managed conservatively with octreotide; a long acting somatostatin analogue. Routine measures had failed, and secondary complications precluded thoracoscopic ligation. We discuss the spectrum of problems associated with chylous fistula and review the rationale behind the use of octreotide.

Entities:  

Keywords:  Chyle; Chylous fistula; Complication; Neck dissection; Octreotide; Octride

Year:  2011        PMID： 25838666      PMCID： PMC4379246          DOI： 10.1007/s12663-011-0269-y

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN： 0972-8270


  11 in total

Review 1.  Management of chylothorax via percutaneous embolization.

Authors:  Constantin Cope
Journal:  Curr Opin Pulm Med       Date:  2004-07       Impact factor: 3.155

Review 2.  Thoracoscopic management of thoracic duct injury: Is there a place for conservatism?

Authors:  S Kumar; A Kumar; D K Pawar
Journal:  J Postgrad Med       Date:  2004 Jan-Mar       Impact factor: 1.476

3.  Octreotide for treating chylothorax after cardiac surgery.

Authors:  Dalokay Kilic; Ekber Sahin; Oner Gulcan; Bulent Bolat; Riza Turkoz; Ahmet Hatipoglu
Journal:  Tex Heart Inst J       Date:  2005

4.  Nutritional management of thoracic duct fistulas. A comparative study of parenteral versus enteral nutrition.

Authors:  W Ramos; J Faintuch
Journal:  JPEN J Parenter Enteral Nutr       Date:  1986 Sep-Oct       Impact factor: 4.016

5.  The use of topical tetracycline in the management of persistent chylous fistulae.

Authors:  R N Kassel; T E Havas; P J Gullane
Journal:  J Otolaryngol       Date:  1987-06

6.  A critical evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic surgery.

Authors:  Daniel J Boffa; Mark J Sands; Thomas W Rice; Sudish C Murthy; David P Mason; Michael A Geisinger; Eugene H Blackstone
Journal:  Eur J Cardiothorac Surg       Date:  2008-01-22       Impact factor: 4.191

7.  Somatostatin analog treatment of a cervical thoracic duct fistula.

Authors:  Carl N Valentine; Roberto Barresi; Richard A Prinz
Journal:  Head Neck       Date:  2002-08       Impact factor: 3.147

8.  Nutritional support in patients with low volume chylous fistula following radical neck dissection.

Authors:  M al-Khayat; G S Kenyon; H V Fawcett; J Powell-Tuck
Journal:  J Laryngol Otol       Date:  1991-12       Impact factor: 1.469

9.  The management of chyle fistula.

Authors:  J D Spiro; R H Spiro; E W Strong
Journal:  Laryngoscope       Date:  1990-07       Impact factor: 3.325

10.  Octreotide in the medical management of chyle fistula.

Authors:  Gurston G Nyquist; Abdulrahman Hagr; Steven E Sobol; Michael P Hier; Martin J Black
Journal:  Otolaryngol Head Neck Surg       Date:  2003-06       Impact factor: 5.591
View more
  4 in total

Review 1.  Chylous fistula: management of a rare complication following right anterior cervical spine approach.

Authors:  Federica Novegno; Pierluigi Granaroli; Luigi Ciccoritti; Pierpaolo Lunardi; Mario Francesco Fraioli
Journal:  Eur Spine J       Date:  2019-02-28       Impact factor: 3.134

Review 2.  Effect of Octreotide in stopping post surgical chyle leak in neck Dissection-A systematic review.

Authors:  Surabhi Magoo; Kalyani Bhate; S N Santhosh Kumar; Pradnya Kakodkar; Monica Gajul; Santoshkumar Mastud
Journal:  J Oral Biol Craniofac Res       Date:  2022-08-20

Review 3.  Management of Chyle Leak after Head and Neck Surgery: Review of Current Treatment Strategies.

Authors:  Sean W Delaney; Haoran Shi; Alireza Shokrani; Uttam K Sinha
Journal:  Int J Otolaryngol       Date:  2017-01-19

4.  Ultrasound-guided percutaneous injection of Pseudomonas aeruginosa-mannose sensitive hemagglutinin for treatment of chyle fistula following neck dissection: Two case reports.

Authors:  Qiang Chen; Yanling Chen; Anping Su; Yu Ma; Boyang Yu; Xiuhe Zou; Dongmei Peng; Jingqiang Zhu
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.